1_img1424895986.jpg 2_img1424896008.jpg 3_img1424896028.jpg 4_img1424896053.jpg
ГЛЕДФАРМ ЛТД intro pharmacovigilance logo-img
  • 1-img1423128723_img1424877095.jpg
  • 2-img1423128732_img1424877082.jpg
  • 3-img1423128813_img1424877070.jpg
  • 4-img1423128825_img1424877057.jpg
  • analiz111_img1422534233.jpg

VIDANOL® tablets

TRANEXAMIC ACID

  • Hemorrhage or risk of hemorrhage in increased generalized fibrinolysis (bleeding during prostate surgery and in the postoperative period, hemorrhagic complications from fibrinolytic therapy) and local fibrinolysis (uterine bleeding, gastrointestinal hemorrhage, epistaxis, posttraumatic hyphema, bleeding after prostatectomy or bladder surgery, tonsillectomy, conization of the cervix, dental extraction in hemophiliacs).
  • Hereditary angioedema.

1 tablet contains Tranexamic acid 500 mg.

Fibrinolysis inhibitors.

 

View instructions Dounload instruction
All Preparations